| |
|
|
 |
- Address:
- 500 Seventh Avenue, 10th floor
New York, NY 10018
- Phone:
- (212) 645-7704
- Website:
- http://www.axonyx.com
-
- Company Information:
-
Axonyx Inc., is located at New York, NY and its mission is to be the leading biopharmaceutical company that develops products and technologies to treat Alzheimer's disease (AD) and other Central Nervous System (CNS) disorders.
Axonyx' business strategy is rooted in four core areas: 1) Focused Pipeline of proprietary compounds that fulfill unmet medical needs, 2) Aggressive Growth Strategy that seeks to leverage in- and out-licensing opportunities, 3) Responsive Operational Network of dedicated high performance and experienced service providers and 4) Financial Strength allowing robust product development and pipeline growth.
Axonyx is currently concentrating financial resources primarily on three compounds in development for Alzheimer's disease, including Phenserine, a symptomatic and disease progression treatment of mild to moderate AD, Posiphen™, a disease progression treatment for AD, and BisNorCymserine (BNC), a symptomatic treatment of severe AD.
|
 |
|
|
